Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry Stedman

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|October 7, 2016
The physical health of Indigenous and non-Indigenous patients participating in residential rehabilitation programs: a comparison studyTom Meehan, Donna Jones, Terry Stedman, et al.
Nursing Reports (Pavia, Italy)|December 27, 2024
Feasibility of Mental Health Triage Call Priority Prediction Using Machine LearningRajib Rana, Niall Higgins, Kazi Nazmul Haque, et al.
Nursing Reports (Pavia, Italy)|November 26, 2025
Passive AI Detection of Stress and Burnout Among Frontline WorkersRajib Rana, Niall Higgins, Terry Stedman, et al.
The Lancet. Psychiatry|June 12, 2025
Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in AustraliaDan Siskind, Andrea Baker, Urska Arnautovska, et al.
BMJ Open|March 4, 2018
CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapineDan Siskind, Nadia Friend, Anthony Russell, et al.
Therapeutic Advances in Psychopharmacology|October 21, 2021
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapineDan Siskind, Anthony W Russell, Shuichi Suetani, et al.
Bjpsych Open|October 3, 2024
Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophreniaDan Siskind, Claudia Bull, Shuichi Suetani, et al.
JAMA Psychiatry|January 17, 2019
Exploring Comorbidity Within Mental Disorders Among a Danish National PopulationOleguer Plana-Ripoll, Carsten Bøcker Pedersen, Yan Holtz, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|October 7, 2016
The physical health of Indigenous and non-Indigenous patients participating in residential rehabilitation programs: a comparison studyTom Meehan, Donna Jones, Terry Stedman, et al.
Nursing Reports (Pavia, Italy)|December 27, 2024
Feasibility of Mental Health Triage Call Priority Prediction Using Machine LearningRajib Rana, Niall Higgins, Kazi Nazmul Haque, et al.
Nursing Reports (Pavia, Italy)|November 26, 2025
Passive AI Detection of Stress and Burnout Among Frontline WorkersRajib Rana, Niall Higgins, Terry Stedman, et al.
The Lancet. Psychiatry|June 12, 2025
Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in AustraliaDan Siskind, Andrea Baker, Urska Arnautovska, et al.
BMJ Open|March 4, 2018
CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapineDan Siskind, Nadia Friend, Anthony Russell, et al.
Therapeutic Advances in Psychopharmacology|October 21, 2021
CoMET: a randomised controlled trial of co-commencement of metformin versus placebo as an adjunctive treatment to attenuate weight gain in patients with schizophrenia newly commenced on clozapineDan Siskind, Anthony W Russell, Shuichi Suetani, et al.
Bjpsych Open|October 3, 2024
Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophreniaDan Siskind, Claudia Bull, Shuichi Suetani, et al.
JAMA Psychiatry|January 17, 2019
Exploring Comorbidity Within Mental Disorders Among a Danish National PopulationOleguer Plana-Ripoll, Carsten Bøcker Pedersen, Yan Holtz, et al.
Pageof 3